COMMUNIQUÉS West-GlobeNewswire

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 15, 2026 it granted stock options to purchase an aggregate of 21,220 shares of common [...]
Vaxart Announces Results of Annual Meeting of Stockholders
17/07/2026
SOUTH SAN FRANCISCO, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based [...]
Immuneering Corporation Announces Grants of Inducement Awards
17/07/2026
NEW YORK, July 17, 2026 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and helping them thrive, previously announced on June [...]
4DMT Announces New Employment Inducement Grants
17/07/2026
EMERYVILLE, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
CAMBRIDGE, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/07/2026
WALTHAM, Mass., July 17, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026
17/07/2026
Rapid oral presentation to highlight overall survival data from the DENALI Part 1b study of azenosertib SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology [...]
Arizona Nonprofit Launches First-Ever Electric Vehicle Fundraiser Featuring the Iconic Volkswagen ID. Buzz
17/07/2026
Family-focused campaign combines innovation, practicality, and purpose to help fund clinical trials for childhood blindness GILBERT, Ariz., July 17, 2026 (GLOBE NEWSWIRE) -- A Race Against Blindness, the Arizona-based [...]
DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars
17/07/2026
Châtillon, France, le 17 juillet 2026 DBV Technologies dépose un prospectus relatif à son Programme At-The-Market (ATM) pour un montant pouvant atteindre 150 millions de dollars DBV Technologies (Euronext : DBV – ISIN [...]
DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales
17/07/2026
Châtillon, France, July 17, 2026 DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
17/07/2026
SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Skyline LASIK Introduces WaveLight® Plus LASIK, Advancing Precision in Vision Correction
17/07/2026
New data presented at the American Academy of Ophthalmology highlights enhanced visual outcomes with next-generation LASIK technology Colorado Springs, CO, July 17, 2026 (GLOBE NEWSWIRE) -- Skyline LASIK is proud to [...]
CARBIOS : Bilan semestriel du contrat de liquidité
17/07/2026
INFORMATION REGLEMENTEE : PERMANENTE Titre concerné : CARBIOS (code ISIN FR0011648716) / Marché concerné : Euronext Growth Paris Clermont-Ferrand (France), le 17 juillet 2026 (18h00 CEST). CARBIOS présente le bilan [...]
Report on Carbios’ liquidity contract
17/07/2026
REGULATED INFORMATION: ONGOING Shares concerned: Carbios (ISIN code: FR0011648716) / Market concerned: Euronext Growth Paris Clermont-Ferrand (France), 17 July 2026 (18:00 CEST). CARBIOS , (Euronext Growth Paris: ALCRB [...]
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology
17/07/2026
Joint presentation with Taipei Medical University, JY BioMed, and HeXun Biosciences highlighted the power of gamma delta (γδ) T cells in eliminating glioblastoma in preclinical studies. TAIPEI, TAIWAN, July 17, 2026 ( [...]
Damora Announces Redomestication from Delaware to Cayman Islands
17/07/2026
BOSTON, July 17, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (Damora or the Company) (NASDAQ: DMRA), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today [...]
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
17/07/2026
Approval of iohexol injection 350 mg iodine/mL in 50 mL, 75 mL and 100 mL vials, and 300 mg iodine/mL in 50 mL vial, significantly expands Amneal’s injectable contrast portfolio Portfolio now positioned to address the [...]
Enovis to Host Second Quarter 2026 Results Conference Call on August 6th
17/07/2026
Dallas, TX, July 17, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to [...]
Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives
17/07/2026
RUTHERFORD, N.J. and SAN DIEGO, July 17, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), together with its operating business Lōkahi Therapeutics™ ("Lōkahi") , a clinical-stage [...]

Pages